SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-14-001087
Filing Date
2014-04-10
Accepted
2014-04-10 14:55:22
Documents
1
Period of Report
2014-04-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4.html 4  
1 OWNERSHIP DOCUMENT form4.xml 4 3580
  Complete submission text file 0001493152-14-001087.txt   5060
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Issuer) CIK: 0001420030 (see all company filings)

IRS No.: 205863618 | Fiscal Year End: 1209
SIC: 2834 Pharmaceutical Preparations

Mailing Address TARGETED MEDICAL PHARMA, INC.,2980 SUITE 301 LOS ANGELES CA 90077
Business Address
Shell William (Reporting) CIK: 0001509917 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53071 | Film No.: 14756750